Firm
Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
Sponsored
Sponsored
-
Sponsored by FB RicePaul Whenman and David Herman of FB Rice explain the concept of a whole of contents document -
Sponsored by Liu, Shen & AssociatesJian Zhang and Jinhua Deng of Liu Shen & Associates consider why a valuable 5G SEP requires a proper patent drafting and prosecution strategy
-
Sponsored by Remfry & SagarCyril Abrol of Remfry & Sagar discusses the regulatory benchmarks for cryptocurrencies and non-fungibles tokens and why India could become a hub of crypto innovation
-
Sponsored by Cabinet Beau de LoménieAurélia Marie of Cabinet Beau de Lomenie considers bad faith trademark filing strategies in the EU
-
Sponsored by GEN Law FirmHe Jing and Gu Xiaoman of GEN Law Firm discuss the key features of China’s patent linkage system
-
Sponsored by Hechanova GroupEditha R Hechanova of Hechanova & Co Inc explores a recent judgment in a two-decade long trademark infringement case between two prominent lechon retailers
